MoHAP and AstraZeneca discuss innovation in pharmaceutical sector

  • Monday 05, August 2019 11:41 AM
  • MoHAP and AstraZeneca discuss innovation in pharmaceutical sector
Sharjah 24: The Ministry of Health and Prevention (MoHAP), represented by Dr. Amin Hussein Al Amiri, Assistant Undersecretary of the Ministry of Health and Prevention’s Public Health Policy and Licenses, received a delegation from AstraZeneca, headed by Mr. Leon Wang, the Executive Vice-President, International, to discuss means of enhancing innovation in the pharmaceutical sector and fostering cooperation to develop treatment of chronic diseases, such as asthma, diabetes and heart diseases.
Commenting on the meeting, AstraZeneca expressed its appreciation for MoHAP’s efforts to speed up the drug registration process for the benefit of both the individual and society.

“Nowadays, we are registering our innovative products in the UAE among the first countries worldwide, after being approved by both the FDA and EMA, thanks to the UAE’s legislative and investment environment that help attract the global pharmaceutical companies and register their innovative products,” added AstraZeneca.

In turn, MoHAP emphasized the importance of coming up with innovative ideas that help bolster the strategic partnership in the pharmaceutical sector, with a view to providing the best means of treatment and reinforcing the UAE’s pharmaceutical economics.

On the sidelines of the meeting, AstraZeneca showcased the technical developments of its premises in Wuxi, China, noting that these developments aim to provide more integrated solutions for patients.